Dose-dependent effects of selenized yeast on total selenium levels in prostatic tissue of men with prostate cancer

Nutrition and Cancer

Volumn 63, Issue 1, 2011, Pages 1-5

  Algotar, A M ^a,b   Stratton, M S ^a   Xu, M J ^a   Dalkin, B L ^c   Nagle, R B ^a   Hsu, C H ^a,b   Ahmann, F R ^a,d   Clark, L C ^a   Stratton, S P ^a,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SELENIUM; SELENOMETHIONINE;

ARTICLE; BLOOD LEVEL; GLEASON SCORE; HUMAN; MALE; PHASE 2 CLINICAL TRIAL (TOPIC); PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELENIZED YEAST; SUPPLEMENTATION; TISSUE LEVEL; YEAST;

AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; SELENIUM; YEASTS;

EID: 78751540025     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.516476     Document Type: Article

References (19)

1. Duffield-Lillico AJ, Slate EH, Reid ME, et al.: Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst 95, 1477-1481, 2003.
2. Clark LC, Combs GF, Jr., Turnbull BW, et al.: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276, 1957-1963, 1996.
3. Yoshizawa K,Willett WC,Morris SJ, et al.: Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 90, 1219-1224, 1998.
4. Blot WJ, Li JY, Taylor PR, et al.: Nutrition intervention trials in Linxian, China: supplementationwith specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85, 1483-1492, 1993.
5. Redman C, Scott JA, Baines AT, et al.: Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Letters 125, 103-10, 1998.
6. Menter DG, Sabichi AL, and Lippman SM: Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev 9, 1171-1182, 2000.
7. Combs GF, Jr.: Considering the mechanisms of cancer prevention by selenium. Advances in Experimental Medicine and Biology 492, 107-117, 2001;.
8. Li H, Stampfer MJ, Giovannucci EL, et al.: A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 96, 696-703, 2004.
9. Gianduzzo TR, Holmes EG, Tinggi U, et al.: Prostatic and peripheral blood selenium levels after oral supplementation. J Urology 170, 870-873, 2003.
10. Sabichi AL, Lee JJ, Taylor RJ, et al.: Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res 12(7, Pt 1), 2178-2184, 2006.
11. Lippman SM, Klein EA, Goodman PJ, et al.: Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39-51, 2009.
12. Clark LC, Dalkin B, Krongrad A, et al.: Decreased incidence of prostate cancer with selenium supplementation: results of a doubleblind cancer prevention trial. British Journal of Urology 81, 730-734, 1998.
13. Naithani R: Organoselenium compounds in cancer chemoprevention. Mini Rev Medicinal Chem 8:657-668, 2008.
14. Heinz GH and Hoffman DJ: Comparison of the effects of seleno-Lmethionine, seleno-DL-methionine, and selenized yeast on reproduction of mallards. Environ Pollut 91, 169-175, 1996.
15. Heinz GH, Hoffman DJ, and LeCaptain LJ: Toxicity of seleno-Lmethionine, seleno-DL-methionine, high-selenium wheat, and selenized yeast to mallard ducklings. Arch Environ Contamination Toxicol 30, 93-99, 1996.
16. Hoffman DJ, Heinz GH, LeCaptain LJ, et al.: Toxicity and oxidative stress of different forms of organic selenium and dietary protein in mallard ducklings. Arch Environ Contamination Toxicol 31, 120-127, 1996.
17. Nasr MA, Fedele MJ, EsserK, and Diamond AM: GPx-1 modulates Akt and P70S6K phosphorylation and Gadd45 levels in MCF-7 cells. Free Radical Biol Med 37, 187-195, 2004.
18. Reid ME, Duffield-Lillico AJ, Slate E, et al.: The nutritional prevention of cancer: 400 mcg per day selenium treatment. Nutr Cancer 60, 155-163, 2008.
19. Stranges S, Marshall JR, Natarajan R, et al.: Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 147, 217-223, 2007.